Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.35 |
| ▸ | CACNA1I | Q9P0X4 | 2/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.31 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22932409 | 0.90 | BACE1 (0.35) | CACNA1ICACNA1GCACNA1HCNR2KCNH2 | |
| SCHEMBL26401362 | 0.82 | ACACB (0.37) | ACACBCACNA1ICACNA1GCACNA1HCNR2 | |
| SCHEMBL19767100 | 0.73 | ACACB (0.37) | ACACBCACNA1ICACNA1GCACNA1HCNR2 | |
| SCHEMBL21078914 | 0.73 | P4HTM (0.41) | ACACBCACNA1ICACNA1GCACNA1HCNR2 | |
| SCHEMBL19767082 | 0.72 | ACACB (0.32) | ACACBCACNA1ICACNA1GCACNA1HCNR2 | |
| SCHEMBL22932412 | 0.72 | BACE1 (0.40) | CACNA1ICACNA1GCACNA1HCNR2KCNH2 | |
| SCHEMBL26401378 | 0.70 | CYP11B1 (0.36) | ACACBP4HTM | |
| SCHEMBL17992215 | 0.65 | BACE1 (0.39) | ACACB | |
| SCHEMBL17992211 | 0.64 | BACE1 (0.37) | CNR2P4HTM | |
| SCHEMBL17992189 | 0.64 | KMT2A (0.41) | ACACBCACNA1ICACNA1GCACNA1HCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779018-B2 | Heterocyclic compound and arthropod pest control composition containing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779018-B2 | Heterocyclic compound and arthropod pest control composition containing same | C5, PRXL2A, NOX3 | ACACB 2404/4885CACNA1I 4192/4885CACNA1G 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.